Decision-making is an essential part of any drug development and is often done in the presence of considerable uncertainty. Confronted with the increasing cost, duration and failure rate of new drug development programs, the use of innovative trial designs and analysis strategies has considerably increased over the past decades. Nevertheless,...
[Read More]